Note: Ingredients listed on restricted chemical lists
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
≥20-≤25 <0.0015
EC/CAS
911-418-6/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
0.06%≤C<0.6 ≥0.6% 0.06%≤C<0.6 ≥0.0015%
General Information
Version
2.01
Revision date
2024-03-14
Product name
FR2-55 SEMI-GLOSS BASE GREY AFNOR 2625
1.2.1 Relevant identified uses
Professional use
supplier name
France
Emergency telephone
+44 (0)1675 432850, +44 (0)344 892 0111
Icons in SDS
Company Information
company name
Sil-Mid Limited
e-mail address of the competent person responsible for the Safety Data Sheet
info@silmid.com
GHS Information
Signal word
No signal word
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable.
Contains
CMIT/MIT(3 1). May produce an allergic reaction. Safety data sheet available on request. Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Not classified. The product is not classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 11 for more detailed information on health effects and symptoms.
